Search results
Results From The WOW.Com Content Network
On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Organic sales growth for the ...
(Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of ...
Image source: The Motley Fool. Abbott Laboratories (NYSE: ABT) Q3 2024 Earnings Call Oct 16, 2024, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.
(Reuters) -A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company ...
(Reuters) -Abbott Laboratories said on Monday the U.S. health regulator had cleared the company's two new over-the-counter glucose monitoring devices, expanding its presence in a fast-growing ...
An Abbott spokesperson said the issue pertains to Similac Probiotic Tri-Blend, which is used by fewer than 200 hospitals, and that it does not apply to any of the company's infant formula products ...
In June, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not ...